High dose thoracic radiotherapy (RT) does not impact lung volume significantly. However, membrane and capillary alteration decreased lung diffusion with full recovery observed in 6 months, according to findings from the French CONORT* study.
A subanalysis of Asian women in the global phase III PALOMA-3* trail showed that a palbociclib/fulvestrant combination overcame endocrine resistance in this population of breast cancer patients as effectively as in the whole study cohort and could be a reasonable therapeutic option, the researchers said.
Immunotherapy with pembrolizumab, an anti-PD-L1 antibody, improved survival in pre-treated advanced non-small-cell lung cancer (NSCLC) patients who were PD-L1 positive compared to docetaxel, according to results from the phase II/III KEYNOTE-010* trial presented at the inaugural European Society for Medical Oncology (ESMO) Asia 2015 Congress held recently in Singapore.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Pharmacist - Malaysia digital copy today!
Tacrolimus is safe and effective in inducing and maintaining remission in paediatric patients with biologic refractory inflammatory bowel disease (IBD), according to a study presented at the 49th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition in Athens, Greece.
Lifetime prevalence of acute pain leading to the use of analgesics approaches 100% in the general population, and pharmacists are a pivotal first point of contact for patients in their journey to better pain management. Noting the need for pharmacists to be more aware of their evolving role as a community pharmacist, GlaxoSmithKline Consumer Healthcare partnered with MIMS Education to organize a workshop that served as a platform for robust knowledge-sharing. Below are highlights from the workshop.